PMC:7463108 / 88236-88460 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T849","span":{"begin":53,"end":58},"obj":"Body_part"},{"id":"T850","span":{"begin":176,"end":183},"obj":"Body_part"}],"attributes":[{"id":"A849","pred":"fma_id","subj":"T849","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A850","pred":"fma_id","subj":"T850","obj":"http://purl.org/sig/ont/fma/fma54527"}],"text":"CCR5-deficiency reduced this ratio by over 2-fold in cells treated with Tat and morphine after 6 h (Fig. 6), indicating a relative increase in mBDNF that may partially protect neurons in the CCR5-deficient glial environment."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T912","span":{"begin":53,"end":58},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T913","span":{"begin":120,"end":121},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"CCR5-deficiency reduced this ratio by over 2-fold in cells treated with Tat and morphine after 6 h (Fig. 6), indicating a relative increase in mBDNF that may partially protect neurons in the CCR5-deficient glial environment."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T85477","span":{"begin":80,"end":88},"obj":"Chemical"}],"attributes":[{"id":"A2062","pred":"chebi_id","subj":"T85477","obj":"http://purl.obolibrary.org/obo/CHEBI_17303"},{"id":"A79091","pred":"chebi_id","subj":"T85477","obj":"http://purl.obolibrary.org/obo/CHEBI_58097"}],"text":"CCR5-deficiency reduced this ratio by over 2-fold in cells treated with Tat and morphine after 6 h (Fig. 6), indicating a relative increase in mBDNF that may partially protect neurons in the CCR5-deficient glial environment."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3235","span":{"begin":72,"end":75},"obj":"Gene"},{"id":"3236","span":{"begin":143,"end":148},"obj":"Gene"},{"id":"3237","span":{"begin":191,"end":195},"obj":"Gene"},{"id":"3240","span":{"begin":80,"end":88},"obj":"Chemical"},{"id":"3243","span":{"begin":0,"end":15},"obj":"Disease"}],"attributes":[{"id":"A3235","pred":"tao:has_database_id","subj":"3235","obj":"Gene:6898"},{"id":"A3236","pred":"tao:has_database_id","subj":"3236","obj":"Gene:12064"},{"id":"A3237","pred":"tao:has_database_id","subj":"3237","obj":"Gene:1234"},{"id":"A3240","pred":"tao:has_database_id","subj":"3240","obj":"MESH:D009020"},{"id":"A3243","pred":"tao:has_database_id","subj":"3243","obj":"MESH:D007153"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"CCR5-deficiency reduced this ratio by over 2-fold in cells treated with Tat and morphine after 6 h (Fig. 6), indicating a relative increase in mBDNF that may partially protect neurons in the CCR5-deficient glial environment."}

{"project":"LitCovid-sentences","denotations":[{"id":"T1164","span":{"begin":0,"end":224},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"CCR5-deficiency reduced this ratio by over 2-fold in cells treated with Tat and morphine after 6 h (Fig. 6), indicating a relative increase in mBDNF that may partially protect neurons in the CCR5-deficient glial environment."}